Erenumab for preventing migraine

Equality Impact Assessment (Guidance development) (PDF 155 KB)

Final draft guidance: 2

Final appraisal document (PDF 320 KB)

Committee papers (PDF 1.42 MB)

Public committee slides (PDF 831 KB)

Appeal

: Appeal letter (PDF 164 KB)

: Scrutiny letter (PDF 162 KB)

: Response to scrutiny letter (PDF 136 KB)

: Final scrutiny letter (PDF 146 KB)

Appeal decision (PDF 233 KB)

Appeal

Final draft guidance

Committee papers (PDF 2.35 MB)

Public committee slides (PDF 1.1 MB)

Public committee slides (PDF 630 KB)

Final appraisal document (PDF 310 KB)

Draft guidance: 1

Appraisal consultation document (PDF 381 KB)

Committee papers (PDF 20.58 MB)

Public committee slides (PDF 774 KB)

Final scope (PDF 213 KB)

Equality impact assessment (Scoping) (PDF 173 KB)

NICE's response to comments on the draft scope and provisional matrix (PDF 358 KB)

Final matrix (PDF 250 KB)

Draft scope pre referral (PDF 297 KB)

Draft matrix pre referral (PDF 248 KB)